Award Recipient 2020


Jeremie Martinet, PharmD, PhD
Rouen University Hospital,
Rouen, France
Immunoglobulins for neuromuscular disorders: immunomodulation and myoregeneration by IVIg in immune-mediated necrotising myopathy (myoRIg)



Award Recipient 2019


Luuk Wieske, MD, PhD
Academic Medical Center (AMC)
Amsterdam, the Netherlands
Serum nerve damage biomarkers for disease activity in IVIg treated patients with chronic inflammatory demyelinating polyneuropathy (CIDP)



Award Recipient 2018


Dr. med. Miriam Fichtner
Yale University
New Haven, Connecticut, USA
IVIG influence on pathogenic B cells in myasthenia gravis



Award Recipient 2017


Ruth Huizinga, PhD
Erasmus University Medical Center
Rotterdam, The Netherlands
Effect of IVIg on the B-cell receptor repertoire of patients with the Guillain-Barré syndrome



Award Recipient 2016


Luis Querol, MD, PhD
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
IVIg effects on regulatory B cells in patients with neuroimmune diseases



Award Recipient 2015


Krista Kuitwaard, MD
Albert Schweitzer Hospital
Dordecht, The Netherlands
Genetic biomarkers associated with IVIg treatment response or dependency in CIDP



Award Recipient 2014


Roland S. Liblau, MD, PhD
Physiopathology Center of Toulouse-Purpan (CPTP)
Toulouse, France
Investigation of the effects of IVIg in a mouse model of autoimmune narcolepsy



Award Recipient 2013


Bart C. Jacobs, PhD, MD
Erasmus University Medical Center
Rotterdam, The Netherlands
Fcγ-receptor gene polymorphisms and the pharmacokinetics of immunoglobulin treatment in the Guillain-Barré syndrome


Award Recipient 2012




Award Recipient 2011




Award Recipient 2010




Award Recipient 2009